Kamyar Ghabili Amirkhiz, MD
Hospital ResidentDownloadHi-Res Photo
Cards
Contact Info
About
Titles
Hospital Resident
Biography
Hometown: Tabriz, Iran
Medical School: Tabriz University of Medical Sciences
Professional Interests: Diagnostic and Interventional Radiology; Clinical Outcomes Research; History of Medicine
Personal Interests: Swimming, painting pottery, reading medieval medical books, and spending time with my wife and friends
Appointments
Departments & Organizations
Education & Training
- General Surgery Resident
- Yale-New Haven Hospital (2021)
- Associate Research Scientist
- Yale School of Medicine (2019)
- Postdoctoral Fellow
- Johns Hopkins Medical Institutions (2017)
- MD
- Tabriz University of Medical Sciences
- ISCOMS Research Fellow
- University Medical Center Groningen (2007)
Research
Overview
Medical Subject Headings (MeSH)
History of Medicine; Kidney Neoplasms; Prostatic Neoplasms; Surgical Oncology; Urinary Bladder Neoplasms; Urologic Neoplasms
Research at a Glance
Yale Co-Authors
Frequent collaborators of Kamyar Ghabili Amirkhiz's published research.
Publications Timeline
A big-picture view of Kamyar Ghabili Amirkhiz's research output by year.
Research Interests
Research topics Kamyar Ghabili Amirkhiz is interested in exploring.
Angelique W. Levi, MD
Darryl T. Martin, PhD
Peter A Humphrey, MD, PhD
13Publications
122Citations
Prostatic Neoplasms
Publications
2022
Percutaneous Chemical and Mechanical Necrosectomy for Walled-Off Pancreatic Necrosis.
Ghabili K, Shaikh J, Pollak J, Elwood D, Majdalany BS, Nezami N. Percutaneous Chemical and Mechanical Necrosectomy for Walled-Off Pancreatic Necrosis. J Vasc Interv Radiol 2022 PMID: 36423816, DOI: 10.1016/j.jvir.2022.11.011.Peer-Reviewed Original Research In Press
2021
Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical Prostatectomy
Ghabili K, Paulson N, Syed JS, Nawaf CB, Khajir G, Martin DT, Onofrey J, Leapman MS, Levi A, Weinreb JC, Humphrey PA, Sprenkle PC. Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical Prostatectomy. Case Reports In Urology 2021, 2021: 2687416. PMID: 33936831, PMCID: PMC8054861, DOI: 10.1155/2021/2687416.Peer-Reviewed Original ResearchAltmetricConceptsBiopsy scoreRadical prostatectomyActive surveillanceBiopsy Gleason grade groupGleason grade group 2Gleason grade group 4Low-risk prostate cancerActive surveillance populationGrade group 4Subsequent surveillance biopsiesOrgan-confined diseaseGrade group 2Gleason grade groupLow-risk categoryBiopsy reclassificationDisease reclassificationSurveillance biopsiesFinal pathologyThird biopsySecond biopsySurveillance populationProstate cancerAdverse featuresGroup 2Genomic score
2019
Outcomes of Serial Multiparametric Magnetic Resonance Imaging and Subsequent Biopsy in Men with Low-risk Prostate Cancer Managed with Active Surveillance
Hsiang W, Ghabili K, Syed JS, Holder J, Nguyen KA, Suarez-Sarmiento A, Huber S, Leapman MS, Sprenkle PC. Outcomes of Serial Multiparametric Magnetic Resonance Imaging and Subsequent Biopsy in Men with Low-risk Prostate Cancer Managed with Active Surveillance. European Urology Focus 2019, 7: 47-54. PMID: 31147263, DOI: 10.1016/j.euf.2019.05.011.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSerial multiparametric magnetic resonance imagingNegative predictive valuePositive predictive valueMultiparametric magnetic resonance imagingPathological upgradeActive surveillanceProstate cancerMagnetic resonance imagingSubsequent biopsyFusion biopsyPredictive valueResonance imagingSerial multiparametric magnetic resonanceLow-risk prostate cancerPI-RADS scoreRisk of reclassificationMultiparametric magnetic resonanceProstate Imaging ReportingBinary logistic regressionInitial mpMRITumor involvementPathological upgradingSystematic biopsyPathological progressionRetrospective analysisRole of Core Number and Location in Targeted Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy
Lu AJ, Syed JS, Ghabili K, Hsiang WR, Nguyen KA, Leapman MS, Sprenkle PC. Role of Core Number and Location in Targeted Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy. European Urology 2019, 76: 14-17. PMID: 31047733, DOI: 10.1016/j.eururo.2019.04.008.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsFusion prostate biopsySignificant prostate cancerProstate cancerProstate biopsyFusion biopsyMagnetic resonance imaging-ultrasound fusion biopsyActive surveillance patientsProstate Imaging ReportingUltrasound fusion biopsyMultiparametric MRI studyMagnetic resonance imagingClinical suspicionSurveillance patientsFirst biopsySystematic biopsySignificant cancerMRI studiesBiopsyPatientsRegion of interestImaging ReportingResonance imagingCancerDistinct cohortsSuspicious areas
2018
Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group Than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-ultrasound Fusion Targeted Biopsies
Martin DT, Ghabili K, Levi A, Humphrey PA, Sprenkle PC. Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group Than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-ultrasound Fusion Targeted Biopsies. Urology 2018, 125: 64-72. PMID: 30552940, DOI: 10.1016/j.urology.2018.12.001.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPI-RADSv2 scoreDecipher scoreProstate Imaging ReportingDecipher testingTargeted biopsiesRadical prostatectomyData System version 2 (PI-RADS v2) scoreFavorable intermediate-risk prostate cancerIntermediate-risk prostate cancer patientsGleason Grade Group 1Imaging ReportingIntermediate-risk prostate cancerMultivariable logistic regression analysisHigh-risk diseasePI-RADS 4Grade group 1Gleason grade groupProstate cancer patientsMultiparametric magnetic resonancePI-RADS scoreVersion 2 scoreData System scoreLogistic regression analysisSignificant differencesPI-RADS categoryCombining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.
Druskin SC, Tosoian JJ, Young A, Collica S, Srivastava A, Ghabili K, Macura KJ, Carter BH, Partin AW, Sokoll LJ, Ross AE, Pavlovich CP. Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer. BJU International 2018, 121: 619-626. PMID: 29232037, DOI: 10.1111/bju.14098.Peer-Reviewed Original Research
2017
Prostate Health Index density improves detection of clinically significant prostate cancer.
Tosoian JJ, Druskin SC, Andreas D, Mullane P, Chappidi M, Joo S, Ghabili K, Mamawala M, Agostino J, Carter HB, Partin AW, Sokoll LJ, Ross AE. Prostate Health Index density improves detection of clinically significant prostate cancer. BJU International 2017, 120: 793-798. PMID: 28058757, DOI: 10.1111/bju.13762.Peer-Reviewed Original ResearchDynamic Contrast Enhanced Magnetic Resonance Imaging Improves Classification of Prostate Lesions: A Study of Pathological Outcomes on Targeted Prostate Biopsy.
Druskin SC, Ward R, Purysko AS, Young A, Tosoian JJ, Ghabili K, Andreas D, Klein E, Ross AE, Macura KJ. Dynamic Contrast Enhanced Magnetic Resonance Imaging Improves Classification of Prostate Lesions: A Study of Pathological Outcomes on Targeted Prostate Biopsy. The Journal Of Urology 2017, 198: 1301-1308. PMID: 28709889, DOI: 10.1016/j.juro.2017.07.011.Peer-Reviewed Original ResearchSafety and Feasibility of Direct Magnetic Resonance Imaging-guided Transperineal Prostate Biopsy Using a Novel Magnetic Resonance Imaging-safe Robotic Device.
Ball MW, Ross AE, Ghabili K, Kim C, Jun C, Petrisor D, Pan L, Epstein JI, Macura KJ, Stoianovici DS, Allaf ME. Safety and Feasibility of Direct Magnetic Resonance Imaging-guided Transperineal Prostate Biopsy Using a Novel Magnetic Resonance Imaging-safe Robotic Device. Urology 2017, 109: 216-221. PMID: 28735018, DOI: 10.1016/j.urology.2017.07.010.Peer-Reviewed Original ResearchUse of the Prostate Health Index for detection of prostate cancer: results from a large academic practice.
Tosoian JJ, Druskin SC, Andreas D, Mullane P, Chappidi M, Joo S, Ghabili K, Agostino J, Macura KJ, Carter HB, Schaeffer EM, Partin AW, Sokoll LJ, Ross AE. Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice. Prostate Cancer And Prostatic Diseases 2017, 20: 228-233. PMID: 28117387, PMCID: PMC5429201, DOI: 10.1038/pcan.2016.72.Peer-Reviewed Original Research
Academic Achievements and Community Involvement
activity Reviewer
Journal ServiceUrologyReviewerDetails03/20/2018 - Presentactivity Reviewer
Journal ServiceJournal of UrologyDetails07/02/2018 - Presentactivity Reviewer
Journal ServiceWorld Journal of SurgeryReviewerDetails08/12/2017 - Presentactivity Editor-in-Chief
Journal ServiceAdvances in Bioscience and Clinical MedicineEditor-in-ChiefDetails04/14/2013 - Presentactivity Reviewer
Journal ServiceBMJ Case ReportsReviewerDetails01/29/2010 - Present